RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $72.00 (from $71.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Stocks expected to have increasing option volume: GILD TTD TTWO EXPE AKAM PODD ELF DBX PARA August 9, 2024 3:27 AM Gilead Sciences (GILD) PT Raised to $90 at JefferiesAugust 9, 2024 2:28 AM Form 10-Q GILEAD SCIENCES, INC. For: Jun 30August 8, 2024 5:19 PM Gilead Sciences (GILD) Tops Q2 EPS by 41c; offers guidanceAugust 8, 2024 4:42 PM Form 8-K GILEAD SCIENCES, INC. For: Aug 08August 8, 2024 4:07 PM Gilead Sciences Announces Second Quarter 2024 Financial ResultsAugust 8, 2024 4:02 PM Gilead Sciences (GILD) option IV elevated, call put ratio 1 call to 1.1 puts into quarte reusltsAugust 7, 2024 10:42 AM Gilead Sciences (GILD) August 9 weekly 74 straddle priced into quarter results August 7, 2024 4:53 AM